2005P-0411
  

  
 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs 

  


  

  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2574
  



  

  
Submitter : 
  

  
Dr. Kara Fitzgerald
  

  
Date & Time: 
  

  
02/16/2006 11:02:55
  



  

  
Organization : 
  

  
Metametrix
  



  

  
Category : 
  

  
Health Professional
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 Clearly, wyeth is violating the law in its attempt to prohibit the sale of safer bioidentical hormones. It is a flagrent attempt to recoup the financial loss it incurred with reduced sales of Premarin.